4.4 Article

A Novel Signature Based on Anoikis Associated with BCR-Free Survival for Prostate Cancer

Related references

Note: Only part of the references are listed.
Article Pharmacology & Pharmacy

SRC Kinase-Mediated Tyrosine Phosphorylation of TUBB3 Regulates Its Stability and Mitotic Spindle Dynamics in Prostate Cancer Cells

Alan Alfano et al.

Summary: Tubulin is a vital component of the cytoskeleton and plays crucial roles in cellular signaling, maintenance, and division. Increased expression of TUBB3, a type of beta-tubulin primarily found in neural cells, is associated with taxane resistance and poor prognosis. Here, we discovered that TUBB3 is phosphorylated at Tyrosine 340 (Y340) by c-Src in prostate cancer cells. Phosphorylation at Y340 regulates TUBB3 protein stability and subcellular localization. Inhibition of SRC kinase activity affects spindle stability in mitotic cells due to the lack of TUBB3 Y340 phosphorylation. Understanding the posttranslational regulation of TUBB3 could serve as potential biomarkers for disease recurrence and treatment failure.

PHARMACEUTICS (2022)

Article Genetics & Heredity

LMO3 downregulation in PCa: A prospective biomarker associated with immune infiltration

Wenchao Xu et al.

Summary: This study utilized various web databases to investigate the prognostic value and molecular functions of LMO3 in prostate cancer (PCa). The results showed that low LMO3 expression in PCa is associated with poor prognosis and is involved in extracellular matrix and immune response. LMO3 may serve as a potential biomarker for immune infiltration in PCa.

FRONTIERS IN GENETICS (2022)

Article Oncology

Immune response drives outcomes in prostate cancer: implications for immunotherapy

Jialin Meng et al.

Summary: A new immune molecular classifier was proposed in this study to classify prostate cancer patients into different immune-activated and immune-suppressed subtypes. The immune-activated subtype was found to be associated with favorable recurrence-free survival outcomes and was predicted to benefit more from anti-PD-1/PD-L1 therapy.

MOLECULAR ONCOLOGY (2021)

Article Cell Biology

Single-cell analysis reveals transcriptomic remodellings in distinct cell types that contribute to human prostate cancer progression

Sujun Chen et al.

Summary: Chen et al. conducted single-cell analysis to identify transcriptomic remodeling in various cell types that regulate prostate cancer progression. They found that the tumor microenvironment displayed activation of progression-associated transcriptomic programs and identified a subset of endothelial cells that actively communicate with tumor cells, promoting cancer cell invasion. Their study also revealed promiscuous KLK3 expression and the ability of cancer cells to alter T-cell transcriptomes.

NATURE CELL BIOLOGY (2021)

Article Oncology

TMPRSS4 promotes cancer stem-like properties in prostate cancer cells through upregulation of SOX2 by SLUG and TWIST1

Yunhee Lee et al.

Summary: TMPRSS4 promotes cancer stem cell features in prostate cancer by upregulating the stem cell factor SOX2 through the EMT-inducing transcription factors SLUG and TWIST1. This novel mechanism may play a crucial role in tumor progression control.

JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH (2021)

Article Medicine, General & Internal

Prostate cancer

Richard J. Rebello et al.

Summary: Prostate cancer is a prevalent disease among men, with key genetic alterations including gene fusions, oncogene amplification, and mutations in androgen receptors. Treatment options range from active surveillance to surgery and radiotherapy for localized disease.

NATURE REVIEWS DISEASE PRIMERS (2021)

Article Computer Science, Artificial Intelligence

Generalized Separable Nonnegative Matrix Factorization

Junjun Pan et al.

Summary: Nonnegative matrix factorization (NMF) is a linear dimensionality technique for nonnegative data, which can be efficiently computed under the separability assumption. The algorithm operates by finding data points that contain basis vectors for decomposition.

IEEE TRANSACTIONS ON PATTERN ANALYSIS AND MACHINE INTELLIGENCE (2021)

Review Biochemistry & Molecular Biology

Immune Checkpoints, Inhibitors and Radionuclides in Prostate Cancer: Promising Combinatorial Therapy Approach

Mankgopo M. Kgatle et al.

Summary: Emerging research indicates that co-inhibitory immune checkpoints are promising immunotherapy targets in various malignancies, but have shown limited effectiveness in advanced prostate cancer treatment. While current PCa treatments initially improve clinical outcomes and survival, they eventually become resistant, leading to aggressive disease. Combining ICIs with radionuclide therapy could potentially enhance efficacy and alter the paradigm of PCa treatment.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2021)

Review Oncology

Mechanisms for Modulating Anoikis Resistance in Cancer and the Relevance of Metabolic Reprogramming

Funmilayo O. Adeshakin et al.

Summary: Cancer cells develop mechanisms to resist anoikis, promoting invasion and metastasis. Understanding the mechanisms driving anoikis resistance is crucial for preventing tumor progression and metastasis, with metabolic pathways playing a key role in helping cells evade anoikis.

FRONTIERS IN ONCOLOGY (2021)

Article Oncology

Possible role of HPV/EBV coinfection in anoikis resistance and development in prostate cancer

Javid Sadri Nahand et al.

Summary: The study evaluated the potential role of HPV and EBV coinfection in prostate cancer development. The findings suggest that HPV/EBV coinfection may influence tumor development and progression through modulation of cellular behaviors.

BMC CANCER (2021)

Review Oncology

The tumor microenvironment and immune responses in prostate cancer patients

J. T. W. Kwon et al.

Summary: The tumor microenvironment of prostate cancer poses particular challenges for immunotherapy, as increased T cell infiltration correlates with a poorer prognosis. The proposal of an immunogenomic subtyping approach may lead to improved outcomes in prostate cancer treatment.

ENDOCRINE-RELATED CANCER (2021)

Article Biochemistry & Molecular Biology

TISCH: a comprehensive web resource enabling interactive single-cell transcriptome visualization of tumor microenvironment

Dongqing Sun et al.

Summary: Cancer immunotherapy targeting co-inhibitory pathways by checkpoint blockade has shown significant efficacy, but only a minority of patients respond due to tumor microenvironment heterogeneity. TISCH is a large curated database that integrates single-cell transcriptomic profiles from 76 high-quality tumor datasets across 27 cancer types, providing a user-friendly interface for exploring gene expression atlas in the TME from multiple cancer types.

NUCLEIC ACIDS RESEARCH (2021)

Review Oncology

Revisiting Immunotherapy: A Focus on Prostate Cancer

Ha-Ram Cha et al.

CANCER RESEARCH (2020)

Article Medicine, General & Internal

Screening for Prostate Cancer

Sigrid Carlsson et al.

MEDICAL CLINICS OF NORTH AMERICA (2020)

Review Oncology

Regulators and mechanisms of anoikis in triple-negative breast cancer (TNBC): A review

Amir Tajbakhsh et al.

CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY (2019)

Article Biochemical Research Methods

GSEA-InContext: identifying novel and common patterns in expression experiments

Rani K. Powers et al.

BIOINFORMATICS (2018)

Review Cell Biology

Genetics and biology of prostate cancer

Guocan Wang et al.

GENES & DEVELOPMENT (2018)

Article Urology & Nephrology

Landmarks in prostate cancer

Niranjan J. Sathianathen et al.

NATURE REVIEWS UROLOGY (2018)

Article Oncology

Prognostic Utility of a New mRNA Expression Signature of Gleason Score

Jennifer A. Sinnott et al.

CLINICAL CANCER RESEARCH (2017)

Editorial Material Oncology

Molecular Signature to Risk-Stratify Prostate Cancer of Intermediate Risk

Yu Yin et al.

CLINICAL CANCER RESEARCH (2017)

Review Radiology, Nuclear Medicine & Medical Imaging

Diagnostic and Therapeutic Strategies for Prostate Cancer

Mary Nguyen-Nielsen et al.

SEMINARS IN NUCLEAR MEDICINE (2016)

Article Dermatology

Biostatistics Series Module 3: Comparing Groups: Numerical Variables

Avijit Hazra et al.

INDIAN JOURNAL OF DERMATOLOGY (2016)

Article Cell Biology

Integrin endosomal signalling suppresses anoikis

Jonna Alanko et al.

NATURE CELL BIOLOGY (2015)

Article Biochemical Research Methods

Robust enumeration of cell subsets from tissue expression profiles

Aaron M. Newman et al.

NATURE METHODS (2015)

Article Biochemistry & Molecular Biology

limma powers differential expression analyses for RNA-sequencing and microarray studies

Matthew E. Ritchie et al.

NUCLEIC ACIDS RESEARCH (2015)

Article Biochemistry & Molecular Biology

The Molecular Signatures Database Hallmark Gene Set Collection

Arthur Liberzon et al.

CELL SYSTEMS (2015)

Article Biochemistry & Molecular Biology

Regulation of anoikis by deleted in breast cancer-1 (DBC1) through NF-κB

Sun Hee Park et al.

APOPTOSIS (2013)

Review Biochemistry & Molecular Biology

Anoikis molecular pathways and its role in cancer progression

Paolo Paoli et al.

BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR CELL RESEARCH (2013)

Article Biochemical Research Methods

GSVA: gene set variation analysis for microarray and RNA-Seq data

Sonja Haenzelmann et al.

BMC BIOINFORMATICS (2013)

Article Biochemistry & Molecular Biology

CCN2 inhibits lung cancer metastasis through promoting DAPK-dependent anoikis and inducing EGFR degradation

C-C Chang et al.

CELL DEATH AND DIFFERENTIATION (2013)

Article Cell Biology

Mechanisms that link the oncogenic epithelial-mesenchymal transition to suppression of anoikis

Steven M. Frisch et al.

JOURNAL OF CELL SCIENCE (2013)

Review Oncology

LIM-domain-only proteins in cancer

Jacqueline M. Matthews et al.

NATURE REVIEWS CANCER (2013)

Review Oncology

Anoikis: an emerging hallmark in health and diseases

M. L. Taddei et al.

JOURNAL OF PATHOLOGY (2012)

Article Oncology

mRNA Expression Signature of Gleason Grade Predicts Lethal Prostate Cancer

Kathryn L. Penney et al.

JOURNAL OF CLINICAL ONCOLOGY (2011)

Article Biochemical Research Methods

ConsensusClusterPlus: a class discovery tool with confidence assessments and item tracking

Matthew D. Wilkerson et al.

BIOINFORMATICS (2010)

Article Urology & Nephrology

Beta-tubulin III expression in prostate cancer

Lars Egevad et al.

SCANDINAVIAN JOURNAL OF UROLOGY AND NEPHROLOGY (2010)

Review Pharmacology & Pharmacy

Anoikis: A necessary death program for anchorage-dependent cells

Paola Chiarugi et al.

BIOCHEMICAL PHARMACOLOGY (2008)

Article Biotechnology & Applied Microbiology

Fibronectin pattern in benign hyperplasia and cancer of the prostate

Miroslava M. Jankovic et al.

DISEASE MARKERS (2008)